Investors sold shares of Amsurg Corp. (NASDAQ:AMSG) on strength during trading on Friday. $14.91 million flowed into the stock on the tick-up and $68.63 million flowed out of the stock on the tick-down, for a money net flow of $53.72 million out of the stock. Of all stocks tracked, Amsurg Corp. had the 0th highest net out-flow for the day. Amsurg Corp. traded up $1.89 for the day and closed at $67.29

Several equities research analysts recently weighed in on the company. Zacks Investment Research downgraded Amsurg Corp. from a “buy” rating to a “hold” rating in a report on Friday, August 5th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $95.00 price target on shares of Amsurg Corp. in a report on Thursday, July 14th. Jefferies Group reaffirmed a “buy” rating on shares of Amsurg Corp. in a report on Sunday, July 3rd. Mizuho increased their price target on Amsurg Corp. from $90.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, June 24th. Finally, Goldman Sachs Group Inc. reaffirmed a “buy” rating on shares of Amsurg Corp. in a report on Friday, June 17th. Four investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $93.91.

The stock has a market cap of $3.62 billion and a P/E ratio of 19.97. The firm has a 50-day moving average of $69.92 and a 200 day moving average of $74.02.

Amsurg Corp. (NASDAQ:AMSG) last released its earnings results on Tuesday, August 2nd. The company reported $1.10 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.08 by $0.02. During the same period last year, the business posted $0.97 earnings per share. The firm earned $758.50 million during the quarter, compared to analyst estimates of $769.88 million. The firm’s quarterly revenue was up 21.5% on a year-over-year basis. On average, equities research analysts anticipate that Amsurg Corp. will post $4.33 earnings per share for the current year.

In other news, insider Robert Jon Coward sold 7,500 shares of Amsurg Corp. stock in a transaction on Friday, August 26th. The stock was sold at an average price of $63.65, for a total value of $477,375.00. Following the completion of the sale, the insider now directly owns 97,507 shares of the company’s stock, valued at approximately $6,206,320.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

A hedge fund recently raised its stake in Amsurg Corp. stock. Dimensional Fund Advisors LP boosted its stake in shares of Amsurg Corp. (NASDAQ:AMSG) by 3.2% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,994,029 shares of the company’s stock after buying an additional 92,088 shares during the period. Dimensional Fund Advisors LP owned 6.27% of Amsurg Corp. worth $227,552,000 at the end of the most recent quarter.

AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.